SYS-CON MEDIA Authors: Pat Romanski, Liz McMillan, Doug Masi, Mat Mathews, PR.com Newswire

News Feed Item

Global Choroidal Neovascularization (CNV) Market 2014-2018.pdf

NEW YORK, Aug. 18, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Choroidal Neovascularization (CNV) Market 2014-2018.pdf

http://www.reportlinker.com/p02170311/Global-Choroidal-Neovascularization-CNV-Market-2014-2018pdf.html

About CNVCNV is defined as a process in which new blood vessels grow in the choroid through the bruch membrane, which is the innermost layer of the choroid, and attack the sub-retinal space. Even though most causes are idiopathic, the known causes are related to degeneration, infections, choroidal tumors and/or trauma. As there is currently no medical treatment for this disease, this abnormal growth can easily lead to impairment of sight or complete loss of vision. TechNavio's analysts forecast the Global CNV market will grow at a CAGR of 6.77 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global CNV market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of CNV

TechNavio's report, the Global CNV Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global CNV market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

• Americas

• EMEA

• APAC

Key Vendors

• Bayer AG

• F. Hoffmann-La Roche Ltd.

• Novartis AG

• Regeneron Pharmaceuticals Inc.

Other Prominent Vendors

• Affitech A/S• Allergan Inc.• Chengdu Kanghong Biotech Co. Ltd.• Gilead Sciences Inc.• Lpath Inc.• Mat Biopharma SAS• Pfizer Inc.• Promedior Inc.• QLT Inc.• Quark Pharmaceuticals Inc.• Resolvyx Pharmaceuticals Inc.• Sanwa Kagaku Kenkyusho Co. Ltd.• Valeant Pharmaceuticals International Inc.

Key Market Driver

• High Patient and Physician Satisfaction.

• For a full, detailed list, view our report.

Key Market Challenge

• High Cost of Treatment.

• For a full, detailed list, view our report.

Key Market Trend

• Strong Competition in the Market.

• For a full, detailed list, view our report.

Key Questions Answered in this Report

• What will the market size be in 2018 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

01. Executive Summary02. List of Abbreviations03. Scope of the Report03.1 Market Overview03.2 Product OfferingsProduct Profiles04. Market Research Methodology04.1 Market Research Process04.2 Research Methodology05. Introduction06. Market Landscape06.1 Market Overview06.2 Market Size and Forecast06.3 Five Forces Analysis07. Product Portfolio of Current CNV Therapies08. Clinical Pipeline Portpolio09. Rate of Incidence and Prevalence09.1.1 US10. Geographical Segmentation10.1 CNV Market in the Americas10.1.1 Market Size and Forecast10.2 CNV Market in the EMEA Region10.2.1 Market Size and Forecast10.3 CNV Market in the APAC Region10.3.1 Market Size and Forecast11. Buying Criteria12. Market Growth Drivers13. Drivers and their Impact14. Market Challenges15. Impact of Drivers and Challenges16. Market Trends17. Trends and their Impact18. Vendor Landscape18.1 Competitive Scenario18.1.1 Key News18.1.2 Mergers and Acquisitions18.2 Market Share Analysis 201318.3 Other Prominent Vendors18.4 Future Vendors to Tap the CNV Market19. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global CNV Market 2013-2018 (US$ million)

Exhibit 3: Global CNV Market by Geographical Segmentation 2013

Exhibit 4: CNV Market in the Americas 2013-2018 (US$ million)

Exhibit 5: CNV Market in the EMEA Region 2013-2018 (US$ million)

Exhibit 6: CNV Market in the APAC Region 2013-2018 (US$ million)

Exhibit 7: Product-wise Revenue Share in Global CNV Market 2013 (in Percentage)

To order this report: Global Choroidal Neovascularization (CNV) Market 2014-2018.pdf http://www.reportlinker.com/p02170311/Global-Choroidal-Neovascularization-CNV-Market-2014-2018pdf.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

 

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.